Literature DB >> 11042677

M1 muscarinic receptors block caspase activation by phosphoinositide 3-kinase- and MAPK/ERK-independent pathways.

C Leloup1, D M Michaelson, A Fisher, T Hartmann, K Beyreuther, R Stein.   

Abstract

When PC12 cells are deprived of trophic support they undergo apoptosis. We have previously shown that survival of trophic factor-deprived PC12M1 cells can be promoted by activation of the G protein-coupled muscarinic receptors. The mechanism whereby muscarinic receptors inhibit apoptosis is poorly understood. In the present study we investigated this mechanism by examining the effect of muscarinic receptor activation on the serum deprivation-induced activity of key players in apoptosis, the caspases, in PC12M1 cells. The results showed that m1 muscarinic activation inhibits caspase activity induced by serum deprivation. This effect appeared to be caused by the prevention of activation of caspases such as caspase-2 and caspase-3, and not by the inhibition of existing activity. Muscarinic receptor activation also stimulated the mitogen-activated protein kinase/extracellular signaling-regulated kinase (MAPK/ERK) and phosphoinositide (PI) 3-kinase signaling pathways. The PI 3-kinase pathway inhibitors wortmannin and LY294002, as well as the MAPK/ERK pathway PD98059 inhibitor, did not however suppress the inhibitory effect of the muscarinic receptors on caspase activity. The results therefore suggested that the muscarinic survival effect is mediated by a pathway that leads to caspase inhibition by MAPK/ERK- and PI 3-kinase-independent signaling cascades.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11042677     DOI: 10.1038/sj.cdd.4400713

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  14 in total

1.  M1 muscarinic receptors modify oxidative stress response to acetaminophen-induced acute liver injury.

Authors:  Nathalie H Urrunaga; Ravirajsinh N Jadeja; Vikrant Rachakonda; Daniel Ahmad; Leon P McLean; Kunrong Cheng; Vijay Shah; William S Twaddell; Jean-Pierre Raufman; Sandeep Khurana
Journal:  Free Radic Biol Med       Date:  2014-10-31       Impact factor: 7.376

2.  Protection from interferon-β-induced neuronal apoptosis through stimulation of muscarinic acetylcholine receptors coupled to ERK1/2 activation.

Authors:  Maria C Olianas; Simona Dedoni; Pierluigi Onali
Journal:  Br J Pharmacol       Date:  2016-08-26       Impact factor: 8.739

3.  Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer.

Authors:  Babak Oskouian; Prathap Sooriyakumaran; Alexander D Borowsky; Angelina Crans; Lisa Dillard-Telm; Yuen Yee Tam; Padmavathi Bandhuvula; Julie D Saba
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-07       Impact factor: 11.205

4.  Muscarinic receptors prevent oxidative stress-mediated apoptosis induced by domoic acid in mouse cerebellar granule cells.

Authors:  Gennaro Giordano; Li Li; Collin C White; Fred M Farin; Hui W Wilkerson; Terrance J Kavanagh; L G Costa
Journal:  J Neurochem       Date:  2009-02-07       Impact factor: 5.372

5.  Activation of M1 mAChRs by lesatropane rescues glutamate neurotoxicity in PC12 cells via PKC-mediated phosphorylation of ERK1/2.

Authors:  Ke Ma; Zhi-Hui Yang; Li-Min Yang; Hong-Zhuan Chen; Yang Lu
Journal:  Bosn J Basic Med Sci       Date:  2013-08       Impact factor: 3.363

6.  Signalling of the M3-muscarinic receptor to the anti-apoptotic pathway.

Authors:  David C Budd; Elizabeth J Spragg; Katie Ridd; Andrew B Tobin
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

Review 7.  M1 muscarinic acetylcholine receptor in Alzheimer's disease.

Authors:  Shangtong Jiang; Yanfang Li; Cuilin Zhang; Yingjun Zhao; Guojun Bu; Huaxi Xu; Yun-Wu Zhang
Journal:  Neurosci Bull       Date:  2014-03-03       Impact factor: 5.203

8.  AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's disease.

Authors:  Abraham Fisher; Rachel Brandeis; Rachel Haring Nira Bar-Ner; Michal Kliger-Spatz; Niva Natan; Hagar Sonego; Itzhak Marcovitch; Zipora Pittel
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

9.  Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation.

Authors:  Rodrigo R Resende; Avishek Adhikari
Journal:  Cell Commun Signal       Date:  2009-08-27       Impact factor: 5.712

Review 10.  M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy.

Authors:  Abraham Fisher; Zipora Pittel; Rachel Haring; Nira Bar-Ner; Michal Kliger-Spatz; Niva Natan; Inbal Egozi; Hagar Sonego; Itzhak Marcovitch; Rachel Brandeis
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 2.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.